[Ip-health] 2010 Prix Galien USA Pro Bono Humanum Award to be Presented to UNITAID for Work In Global HIV/AIDS Effort

Thiru Balasubramaniam thiru at keionline.org
Wed Sep 29 04:15:13 PDT 2010


2010 Prix Galien USA Pro Bono Humanum Award to be Presented to UNITAID  
for Work In Global HIV/AIDS Effort

Clinton Health Access Initiative also to be Awarded Citation of Honor  
for Support of UNITAID Effort; Winners to be Honored at Awards Gala on  
Sept. 28 in NYC
NEW YORK, Sept. 9 /PRNewswire/ -- The Prix Galien USA committee,  
responsible for awarding  the most prestigious prize in  
biopharmaceutical research and development, today announced the 2010  
winner of the Pro Bono Humanum Award for the 4th annual Prix Galien  
USA Awards competition. The award, recognizing exemplary and  
innovative efforts to improve the human condition, will be presented  
to UNITAID in partnership with the Clinton Health Access Initiative  
(CHAI) for their tremendous work combating the global HIV/AIDS epidemic.

Philippe Douste-Blazy, M.D., President of UNITAID, and President  
William J. Clinton, President of CHAI, will be accepting the award on  
behalf of their organizations. UNITAID and CHAI's efforts to reduce  
the price of quality medicines and diagnostics, while accelerating the  
pace at which these health products are made available, have resulted  
in the distribution of life-saving medicines to more than 456,000  
people in 40 countries.

Elie Wiesel, Nobel Laureate and Prix Galien USA committee member, will  
present the award at a black tie ceremony at the American Museum of  
Natural History in New York City on September 28, 2010. The Prix  
Galien USA Pro Bono Humanum Award will accompany a series of other  
awards honoring companies who have made innovative contributions to  
biopharmaceutical and medical technology research and development.

"The collaboration between UNITAID and the Clinton Health Access  
Initiative truly embodies the spirit of the Pro Bono Award by moving  
us forward in improving the human condition, particularly for those  
affected by HIV/AIDS. The combination of innovative financing,  
philanthropic goals, and effective delivery of medicines makes this  
award and citation natural winners for the 2010 Pro Bono Award," said  
Gerald Weissmann, M.D., Prix Galien USA committee chair, New York  
University professor emeritus and editor-in-chief of The FASEB  
Journal. "Because of this partnership, three out of four children with  
AIDS are now being treated, and there has been a sharp reduction in  
the price of antiretroviral treatments for patients."

Each year, the Prix Galien USA committee awards a special Pro Bono  
Humanum Award to an individual, a company, an academic institution or  
a non-governmental agency that has helped to improve the human  
condition through the application of pharmaceutical science to  
problems of developing or underserved populations worldwide. Recent  
winners of the Pro Bono Humanum Award include: Dr. Roy Vagelos for his  
campaign to eradicate river blindness in 2007; Dr. Sheldon Segal and  
the Population Council in 2008 for their role in developing  
implantable hormone delivery systems and to Dr. Barry Bloom with Dr.  
Jeffrey Sachs in 2009 for their efforts with the Harvard School Public  
Health/Earth Institute to eradicate disease by understanding the  
immune responses to infectious diseases.

The Prix Galien recognizes the technical, scientific and clinical  
research skills necessary to develop innovative medicines and devices  
such as these, and is considered the industry's highest accolade,  
equivalent to the Nobel Prize. Prix Galien was first established in  
1970 by French pharmacist Roland Mehl and was inaugurated in the  
United States in September 2007. The Prix Galien USA Award committee  
comprises 11 individuals including Nobel Laureates, founders of major  
biotech companies and editors of world-renowned biology journals. For  
details about the Prix Galien USA Award and Committee, or to learn  
more about the Awards Gala, visit www.prix-galienusa.com.


Thiru Balasubramaniam
Geneva Representative
Knowledge Ecology International (KEI)
thiru at keionline.org

Tel: +41 22 791 6727
Mobile: +41 76 508 0997

More information about the Ip-health mailing list